Nabriva Therapeutics plc
Pagina dedicata companiei Nabriva Therapeutics plc listata cu simbolurile US.NBRV, US.NBRVn
Descriere companie[edit | ]
Nabriva Therapeutics plc (https://www.nabriva.com/) is a biopharmaceutical company engaged in the commercialization and development of anti-infective agents to treat serious infections. The Company’s product XENLETA (lefamulin), is a semi-synthetic pleuromutilin antibiotic for systematic administration in humans. It inhibits the synthesis of bacterial protein, which is required for bacteria to grow by binding with high affinity, high specificity and at molecular targets that are different than other antibiotic classes. The Company is also developing CONTEPO (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis.
Grafic actiuni companie[edit | ]